Cargando…

Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice

Bladder cancer represents a significant human tumor burden, accounting for about 7.7% and 2.4% of all cancer cases in males and females, respectively. While men have a higher risk of developing bladder cancer, women tend to present at a later stage of disease and with more aggressive tumors. Previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Daniel T., Hooker, Erika, Luong, Richard, Yu, Eun-Jeong, He, Yongfeng, Gonzalgo, Mark L., Sun, Zijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749068/
https://www.ncbi.nlm.nih.gov/pubmed/26862755
http://dx.doi.org/10.1371/journal.pone.0148851
_version_ 1782415221693874176
author Johnson, Daniel T.
Hooker, Erika
Luong, Richard
Yu, Eun-Jeong
He, Yongfeng
Gonzalgo, Mark L.
Sun, Zijie
author_facet Johnson, Daniel T.
Hooker, Erika
Luong, Richard
Yu, Eun-Jeong
He, Yongfeng
Gonzalgo, Mark L.
Sun, Zijie
author_sort Johnson, Daniel T.
collection PubMed
description Bladder cancer represents a significant human tumor burden, accounting for about 7.7% and 2.4% of all cancer cases in males and females, respectively. While men have a higher risk of developing bladder cancer, women tend to present at a later stage of disease and with more aggressive tumors. Previous studies have suggested a promotional role of androgen signaling in enhancing bladder cancer development. To directly assess the role of androgens in bladder tumorigenesis, we have developed a novel transgenic mouse strain, R26hAR(LoxP/+):Upk3a(GCE/+), in which the human AR transgene is conditionally expressed in bladder urothelium. Intriguingly, both male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice display a higher incidence of urothelial cell carcinoma (UCC) than the age and sex matched control littermates in response to the carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). We detect expression of the human AR transgene in CK5-positive and p63-positive basal cells in bladder urothelium. Further analyses of UCC tissues from R26hAR(LoxP/+):Upk3a(GCE/+) mice showed that the majority of tumor cells are of urothelial basal cell origin. Positive immunostaining of transgenic AR protein was observed in the majority of tumor cells of the transgenic mice, providing a link between transgenic AR expression and oncogenic transformation. We observed an increase in Ki67 positive cells within the UCC lesions of transgenic AR mice. Manipulating endogenous androgen levels by castration and androgen supplementation directly affected bladder tumor development in male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice, respectively. Taken together, our data demonstrate for the first time that conditional activation of transgenic AR expression in bladder urothelium enhances carciongen-induced bladder tumor formation in mice. This new AR transgenic mouse line mimics certain features of human bladder cancer and can be used to study bladder tumorigenesis and for drug development.
format Online
Article
Text
id pubmed-4749068
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47490682016-02-26 Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice Johnson, Daniel T. Hooker, Erika Luong, Richard Yu, Eun-Jeong He, Yongfeng Gonzalgo, Mark L. Sun, Zijie PLoS One Research Article Bladder cancer represents a significant human tumor burden, accounting for about 7.7% and 2.4% of all cancer cases in males and females, respectively. While men have a higher risk of developing bladder cancer, women tend to present at a later stage of disease and with more aggressive tumors. Previous studies have suggested a promotional role of androgen signaling in enhancing bladder cancer development. To directly assess the role of androgens in bladder tumorigenesis, we have developed a novel transgenic mouse strain, R26hAR(LoxP/+):Upk3a(GCE/+), in which the human AR transgene is conditionally expressed in bladder urothelium. Intriguingly, both male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice display a higher incidence of urothelial cell carcinoma (UCC) than the age and sex matched control littermates in response to the carcinogen, N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). We detect expression of the human AR transgene in CK5-positive and p63-positive basal cells in bladder urothelium. Further analyses of UCC tissues from R26hAR(LoxP/+):Upk3a(GCE/+) mice showed that the majority of tumor cells are of urothelial basal cell origin. Positive immunostaining of transgenic AR protein was observed in the majority of tumor cells of the transgenic mice, providing a link between transgenic AR expression and oncogenic transformation. We observed an increase in Ki67 positive cells within the UCC lesions of transgenic AR mice. Manipulating endogenous androgen levels by castration and androgen supplementation directly affected bladder tumor development in male and female R26hAR(LoxP/+):Upk3a(GCE/+) mice, respectively. Taken together, our data demonstrate for the first time that conditional activation of transgenic AR expression in bladder urothelium enhances carciongen-induced bladder tumor formation in mice. This new AR transgenic mouse line mimics certain features of human bladder cancer and can be used to study bladder tumorigenesis and for drug development. Public Library of Science 2016-02-10 /pmc/articles/PMC4749068/ /pubmed/26862755 http://dx.doi.org/10.1371/journal.pone.0148851 Text en © 2016 Johnson et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Johnson, Daniel T.
Hooker, Erika
Luong, Richard
Yu, Eun-Jeong
He, Yongfeng
Gonzalgo, Mark L.
Sun, Zijie
Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
title Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
title_full Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
title_fullStr Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
title_full_unstemmed Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
title_short Conditional Expression of the Androgen Receptor Increases Susceptibility of Bladder Cancer in Mice
title_sort conditional expression of the androgen receptor increases susceptibility of bladder cancer in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749068/
https://www.ncbi.nlm.nih.gov/pubmed/26862755
http://dx.doi.org/10.1371/journal.pone.0148851
work_keys_str_mv AT johnsondanielt conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice
AT hookererika conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice
AT luongrichard conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice
AT yueunjeong conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice
AT heyongfeng conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice
AT gonzalgomarkl conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice
AT sunzijie conditionalexpressionoftheandrogenreceptorincreasessusceptibilityofbladdercancerinmice